Understanding What Is the Mechanism of Action of BTK Inhibitors?
•
4 min read
BTK inhibitors have revolutionized the treatment landscape for many B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), by providing a highly effective alternative to traditional chemotherapy. The core principle behind these targeted therapies is understanding **what is the mechanism of action of BTK inhibitors** and how they disrupt the specific pathways that fuel cancer growth.
